SCHEMBL1628895

SCHEMBL1628895

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1C=Cc1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 8/20 0.42
HSP90AA1 P07900 1/20 0.39
KCNN4 O15554 1/20 0.37
RELA Q04206 1/20 0.36
CYP1A1 P04798 3/20 0.35
CYP1B1 Q16678 3/20 0.35
MAPK14 Q16539 1/20 0.35
CYP1A2 P05177 2/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 2/20 0.34
NR3C2 P08235 1/20 0.34
TRPA1 O75762 1/20 0.34
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628894 1.00 NFE2L2 (0.42) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1628551 0.92 CYP1A1 (0.41) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1628547 0.92 CYP1A1 (0.41) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1630510 0.90 NFE2L2 (0.46) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1630512 0.90 NFE2L2 (0.46) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1631540 0.90 CYP1A1 (0.43) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1631539 0.90 CYP1A1 (0.43) NFE2L2HSP90AA1KCNN4RELACYP1A1
SCHEMBL1629065 0.88 NFE2L2 (0.42) NFE2L2HSP90AA1KCNN4RELAMAPK14
SCHEMBL1629067 0.88 NFE2L2 (0.42) NFE2L2HSP90AA1KCNN4RELAMAPK14
SCHEMBL1630458 0.84 HSP90AA1 (0.44) NFE2L2HSP90AA1KCNN4MAPK14NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P NFE2L2 1367/4885HSP90AA1 2/4885KCNN4 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.